2 active not recruiting, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 2, Withdrawn 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Refractory B Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory B Lymphoblastic Lymphoma trials Research Report on Refractory B Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia Biospecimen Collection, Computed Tomography, Lumbar Puncture - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 40 | 2018-08-13 | 2026-10-06 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Withdrawn | University of Washington | 2018-07-01 | 2018-11-14 | |
| Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration and Biopsy - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 2 | Active not recruiting | Children's Oncology Group | 80 | 2017-06-19 | 2026-10-01 |
Burkitt Lymphoma (3) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Lymphoma (1)
DNA Virus Infections (3) · Epstein-Barr Virus Infections (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Herpesviridae Infections (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Infections (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoma, B-Cell (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3)
Vincristine (3) · Asparaginase (2) · Cyclophosphamide (2) · Specimen Handling (2) · Spinal Puncture (2) · Biopsy (1) · Cytarabine (1) · Doxorubicin (1) · Etoposide (1) · Imatinib Mesylate (1) · Inotuzumab Ozogamicin (1) · Leucovorin (1) · Leyk (1) · Magnetic Resonance Spectroscopy (1) · Methotrexate (1)
Children's Oncology Group (1) · ECOG-ACRIN Cancer Research Group (1) · University of Washington (1)
United States (3) · Puerto Rico (2)
Maureen M O'Brien (1) · Neil D Palmisiano (1) · Ryan Cassaday (1)
PMID 35007127, PMID 35622074, PMID 39415930, PMID 41671463
P30CA015704 (1), U10CA180820 (1), U10CA180886 (1)